federal enforcement actions, filings and court records, from official sources

••• ⚠️ Newsticker presented by CFExclusion.com ⚠️ ••• 🚨 FRAUD WATCH — Federal authorities announced charges against 16 noncitizens in alleged election-related crimes, including illegal voting and fraudulent voter registration; defendants remain presumed innocent.  • 🤖 AI SECURITY — Researchers report autonomous AI agents attempting hacking techniques against government websites, while malicious AI tools are increasingly being used in cyberattacks.  • 💻 ONLINE THEFT — The FBI says multiple suspects have been arrested in the ShinyHunters data-theft investigation following attacks involving stolen information and extortion.  • 🇺🇸 TRUMP — Trump announced a federal “Super Intelligence Force” to coordinate America’s AI strategy and maintain U.S. technological leadership.  • 🏛️ POLITICS — With one month until the midterms, control of Congress is tightening into a major national battle.  • 🔎 AI SCREENING — As fraud, stolen identities and automated attacks accelerate, AI-based scre

Records through Monday, October 12, 2026 DOJ · SEC · FTC · FDA · CFPB · CFTC · FINRA · OCC · Federal Register · CourtListener · SCOTUSblog

U.S. Food and Drug Administration · FDA enforcement report entry

FDA Class II: Baxter Healthcare Corporation — Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dos

The U.S. Food and Drug Administration listed this entry in its enforcement reports on September 9, 2026. The source link opens the FDA’s recalls, market withdrawals and safety alerts page.

Read the official source on fda.gov →

Issued by: U.S. Food and Drug Administration
Document type: FDA enforcement report entry
Date: September 9, 2026
First recorded by CourtPulse: September 15, 2026 · all records that day
Category: FDA action (assigned by CourtPulse)

CourtPulse lists public records with a link to the official source. The title is shown as the source published it; this page adds no commentary.

More from U.S. Food and Drug Administration, within 7 days

FDA Class II: Baxter Healthcare Corporation — MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, B Sep 9, 2026 · FDA enforcement report entry
FDA Class II: Lexia LLC — Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, Hemp Sep 9, 2026 · FDA enforcement report entry
FDA Class II: Baxter Healthcare Corporation — Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Conta Sep 9, 2026 · FDA enforcement report entry
FDA Class II: Baxter Healthcare Corporation — Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL (4 mcg/mL) in Ga Sep 9, 2026 · FDA enforcement report entry
FDA Class II: Baxter Healthcare Corporation — Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Co Sep 9, 2026 · FDA enforcement report entry
FDA Class II: Baxter Healthcare Corporation — Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Container, sterile, Nonp Sep 9, 2026 · FDA enforcement report entry

Get records like this one daily by email →